Cargando…
Imageable AuNP-ECM Hydrogel Tissue Implants for Regenerative Medicine
In myocardial infarction, a blockage in one of the coronary arteries leads to ischemic conditions in the left ventricle of the myocardium and, therefore, to significant death of contractile cardiac cells. This process leads to the formation of scar tissue, which reduces heart functionality. Cardiac...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10141701/ https://www.ncbi.nlm.nih.gov/pubmed/37111783 http://dx.doi.org/10.3390/pharmaceutics15041298 |
_version_ | 1785033441883979776 |
---|---|
author | Shilo, Malka Baruch, Ester-Sapir Wertheim, Lior Oved, Hadas Shapira, Assaf Dvir, Tal |
author_facet | Shilo, Malka Baruch, Ester-Sapir Wertheim, Lior Oved, Hadas Shapira, Assaf Dvir, Tal |
author_sort | Shilo, Malka |
collection | PubMed |
description | In myocardial infarction, a blockage in one of the coronary arteries leads to ischemic conditions in the left ventricle of the myocardium and, therefore, to significant death of contractile cardiac cells. This process leads to the formation of scar tissue, which reduces heart functionality. Cardiac tissue engineering is an interdisciplinary technology that treats the injured myocardium and improves its functionality. However, in many cases, mainly when employing injectable hydrogels, the treatment may be partial because it does not fully cover the diseased area and, therefore, may not be effective and even cause conduction disorders. Here, we report a hybrid nanocomposite material composed of gold nanoparticles and an extracellular matrix-based hydrogel. Such a hybrid hydrogel could support cardiac cell growth and promote cardiac tissue assembly. After injection of the hybrid material into the diseased area of the heart, it could be efficiently imaged by magnetic resonance imaging (MRI). Furthermore, as the scar tissue could also be detected by MRI, a distinction between the diseased area and the treatment could be made, providing information about the ability of the hydrogel to cover the scar. We envision that such a nanocomposite hydrogel may improve the accuracy of tissue engineering treatment. |
format | Online Article Text |
id | pubmed-10141701 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-101417012023-04-29 Imageable AuNP-ECM Hydrogel Tissue Implants for Regenerative Medicine Shilo, Malka Baruch, Ester-Sapir Wertheim, Lior Oved, Hadas Shapira, Assaf Dvir, Tal Pharmaceutics Article In myocardial infarction, a blockage in one of the coronary arteries leads to ischemic conditions in the left ventricle of the myocardium and, therefore, to significant death of contractile cardiac cells. This process leads to the formation of scar tissue, which reduces heart functionality. Cardiac tissue engineering is an interdisciplinary technology that treats the injured myocardium and improves its functionality. However, in many cases, mainly when employing injectable hydrogels, the treatment may be partial because it does not fully cover the diseased area and, therefore, may not be effective and even cause conduction disorders. Here, we report a hybrid nanocomposite material composed of gold nanoparticles and an extracellular matrix-based hydrogel. Such a hybrid hydrogel could support cardiac cell growth and promote cardiac tissue assembly. After injection of the hybrid material into the diseased area of the heart, it could be efficiently imaged by magnetic resonance imaging (MRI). Furthermore, as the scar tissue could also be detected by MRI, a distinction between the diseased area and the treatment could be made, providing information about the ability of the hydrogel to cover the scar. We envision that such a nanocomposite hydrogel may improve the accuracy of tissue engineering treatment. MDPI 2023-04-20 /pmc/articles/PMC10141701/ /pubmed/37111783 http://dx.doi.org/10.3390/pharmaceutics15041298 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Shilo, Malka Baruch, Ester-Sapir Wertheim, Lior Oved, Hadas Shapira, Assaf Dvir, Tal Imageable AuNP-ECM Hydrogel Tissue Implants for Regenerative Medicine |
title | Imageable AuNP-ECM Hydrogel Tissue Implants for Regenerative Medicine |
title_full | Imageable AuNP-ECM Hydrogel Tissue Implants for Regenerative Medicine |
title_fullStr | Imageable AuNP-ECM Hydrogel Tissue Implants for Regenerative Medicine |
title_full_unstemmed | Imageable AuNP-ECM Hydrogel Tissue Implants for Regenerative Medicine |
title_short | Imageable AuNP-ECM Hydrogel Tissue Implants for Regenerative Medicine |
title_sort | imageable aunp-ecm hydrogel tissue implants for regenerative medicine |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10141701/ https://www.ncbi.nlm.nih.gov/pubmed/37111783 http://dx.doi.org/10.3390/pharmaceutics15041298 |
work_keys_str_mv | AT shilomalka imageableaunpecmhydrogeltissueimplantsforregenerativemedicine AT baruchestersapir imageableaunpecmhydrogeltissueimplantsforregenerativemedicine AT wertheimlior imageableaunpecmhydrogeltissueimplantsforregenerativemedicine AT ovedhadas imageableaunpecmhydrogeltissueimplantsforregenerativemedicine AT shapiraassaf imageableaunpecmhydrogeltissueimplantsforregenerativemedicine AT dvirtal imageableaunpecmhydrogeltissueimplantsforregenerativemedicine |